-+ 0.00%
-+ 0.00%
-+ 0.00%

MEDTIDE - SUBSIDIARY COMPLETES U.S. FDA PRE-LICENSE INSPECTION AT HANGZHOU FACILITY

Reuters·07/31/2026 08:33:58

Please log in to view news